CNS & Neurological Disorders - Drug Targets

Formerly Current Drug Targets - CNS & Neurological Disorders

Editor-in-Chief

Edoardo Spina
Department of Clinical and Experimental Medicine
University of Messina
Policlinico Universitario
Via Consolare Valeria
Messina
(Italy)

Personal Subscription
Become EABM
Become Reviewer
Call for Editor
Volume: 6 Issue: 3, June

Editorial [Hot Topic: Depression (Part 2) (Guest Editors: Ronald S. Duman and John H. Kehne)]

Volume:6   Issue: 3
Pp: 161-162
Ronald S. Duman and John H. Kehne
DOI: 10.2174/187152707780619317
Published on: 01 March, 2012

The Brain Galanin Receptors: Targets for Novel Antidepressant Drugs

Volume:6   Issue: 3
Pp: 183-192
Xiaoying Lu, Lisa Sharkey and Tamas Bartfai
DOI: 10.2174/187152707780619335
Published on: 01 March, 2012

Targeting Signal Transduction Pathways in the Treatment of Mood Disorders: Recent Insights into the Relevance of the Wnt Pathway

Volume:6   Issue: 3
Pp: 193-204
Todd D. Gould, Eliot R. Dow, Kelley C. O'Donnell, Guang Chen and Husseini K. Manji
DOI: 10.2174/187152707780619308
Published on: 01 March, 2012

Adult Hippocampal Neurogenesis as Target for the Treatment of Depression

Volume:6   Issue: 3
Pp: 205-218
Michael R. Drew and Rene Hen
DOI: 10.2174/187152707780619353
Published on: 01 March, 2012

Gliogenesis and Glial Pathology in Depression

Volume:6   Issue: 3
Pp: 219-233
G. Rajkowska and J. J. Miguel-Hidalgo
DOI: 10.2174/187152707780619326
Published on: 01 March, 2012